Kiromic BioPharma, Inc. - Common Stock (NQ:KRBP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kiromic BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 03, 2023

Via Benzinga

Why Guardforce AI Shares Are Trading Lower By 59%; Here Are 20 Stocks Moving Premarket ↗

May 03, 2023

Gainers Aptorum Group Limited (NASDAQ: APM) gained 164.3% to $7.40 in pre-market trading after gaining 8% on Tuesday. Aptorum Group recently reported 2022 fiscal year-end financial results and issued...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 03, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 01, 2023

Via Benzinga

Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer

May 01, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 04, 2023

Via Benzinga

Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 04, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43.

Via Benzinga

Kiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung Cancer

April 03, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 15, 2023

Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.

Via Benzinga

Bluegreen Vacations, Eagle Pharmaceuticals And 3 Stocks To Watch Heading Into Monday ↗

March 13, 2023

With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Kiromic BioPharma Announces Reverse Stock Split

March 10, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 09, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 08, 2023

Via Benzinga

Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results

February 28, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.

Via Benzinga

Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 24, 2023

Via Benzinga

Two Leading Independent Proxy Advisory Firms Recommend Kiromic BioPharma Stockholders Vote “FOR” All Proxy Proposals

February 23, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

Kiromic BioPharma CEO Issues Letter to Stockholders

February 16, 2023

From Kiromic BioPharma, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 07, 2023

Via Benzinga

Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 27, 2023

Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 26, 2023

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.